An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms

INTRODUCTION: Tourette syndrome (TS) is a childhood-onset neurobehavioral disorder characterized by tics. Pharmacotherapy is advised for patients whose symptoms affect their quality of life.

via https://pubmed.ncbi.nlm.nih.gov/39034647/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20240723010806&v=2.18.0.post9+e462414